Gastroenterology News

Treatment with Stelara for inflammatory bowel disease did not increase the risk for adverse maternal or fetal pregnancy outcomes, and infants exposed in utero reached developmental milestones in the first year of life, data showed.

In this Healio video exclusive, Michael V. Chiorean, MD, explains that physicians can safely and “with confidence” switch patients with inflammatory bowel disease from an originator biologic to a biosimilar at any point during treatment.

The FDA has approved Simlandi as the third interchangeable biosimilar to Humira following a rejection in April 2023 stemming from issues at the developer’s manufacturing facility.

Although neurokinin-1 receptor antagonist tradipitant did not outperform placebo in improving nausea severity at 12 weeks in patients with gastroparesis, those with adequate tradipitant exposure did achieve overall symptom improvement.

Anita Afzali, MD, MPH, FACG, executive vice chair of medicine and professor of clinical medicine at University of Cincinnati College of Medicine,  spoke with Healio about ulcerative colitis.

Anita Afzali, MD, MPH, FACG, executive vice chair of medicine and professor of clinical medicine at University of Cincinnati College of Medicine,  spoke with Healio about ulcerative colitis.

Anita Afzali, MD, MPH, FACG, executive vice chair of medicine and professor of clinical medicine at University of Cincinnati College of Medicine,  spoke with Healio about ulcerative colitis.

Anita Afzali, MD, MPH, FACG, executive vice chair of medicine and professor of clinical medicine at University of Cincinnati College of Medicine,  spoke with Healio about ulcerative colitis.

In this Healio video, Rasmi Nair, MBBS, MPH, PhD, reports findings from a recent study, which showed 10% of at-home fecal immunological tests for colorectal cancer screening could not be processed, mostly due to specimen errors.

Researchers at Cleveland Clinic identified differences in tumor-related bacteria that may improve understanding of young-onset colorectal cancer.